Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04914897
Title A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | FRA | ESP | AUS | ARG

Facility Status City State Zip Country Details
Thomas Jefferson University Hospital Site Number : 8400009 Philadelphia Pennsylvania 19107 United States Details
Thomas Jefferson University - North East Site Number : 8401009 Philadelphia Pennsylvania 19114 United States Details
Investigational Site Number : 0320002 Caba Buenos Aires 1430 Argentina Details
Investigational Site Number : 0360002 Richmond Victoria 3121 Australia Details
Investigational Site Number : 1520005 Santaigo Reg Metropolitana De Santiago 8241470 Chile Details
Investigational Site Number : 1520004 Santiago Reg Metropolitana De Santiago 7500713 Chile Details
Investigational Site Number : 1520002 Santiago Reg Metropolitana De Santiago 7500921 Chile Details
Investigational Site Number : 1520001 Santiago Reg Metropolitana De Santiago 8420383 Chile Details
Investigational Site Number : 1520003 Temuco 4800827 Chile Details
Investigational Site Number : 2500006 Bordeaux Cedex France Details
Investigational Site Number : 2500005 Paris 75018 France Details
Investigational Site Number : 2500001 Saint Herblain 44800 France Details
Investigational Site Number : 2500003 Toulouse 31059 France Details
Investigational Site Number : 3800005 Aviano (PN) Friuli-Venezia Giulia 33081 Italy Details
Investigational Site Number : 3800001 Rozzano Milano 20089 Italy Details
Investigational Site Number : 3800002 Orbassano Torino 10043 Italy Details
Investigational Site Number : 3800006 Bologna 40138 Italy Details
Investigational Site Number : 3800004 Milano 20133 Italy Details
Investigational Site Number : 3800008 Padova 35128 Italy Details
Investigational Site Number : 3920001 Sapporo-shi Hokkaido 003-0804 Japan Details
Investigational Site Number : 4100002 Seoul Seoul-teukbyeolsi 03080 Korea, Republic of Details
Investigational Site Number : 4100003 Seoul Seoul-teukbyeolsi 05505 Korea, Republic of Details
Investigational Site Number : 4100001 Seoul Seoul-teukbyeolsi 06351 Korea, Republic of Details
Investigational Site Number : 6160001 Warszawa Mazowieckie 02-781 Poland Details
Investigational Site Number : 6160003 Gdansk Pomorskie 80-214 Poland Details
Investigational Site Number : 6160004 Olsztyn Warminsko-mazurskie 10-357 Poland Details
Investigational Site Number : 6160002 Poznan Wielkopolskie 60-693 Poland Details
Investigational Site Number : 7240006 Barcelona Barcelona [Barcelona] 08035 Spain Details
Investigational Site Number : 7240003 Girona Girona [Gerona] 17007 Spain Details
Investigational Site Number : 7240004 Madrid Madrid, Comunidad De 28046 Spain Details
Investigational Site Number : 7240002 Madrid 28034 Spain Details
Investigational Site Number : 7240001 Madrid 28041 Spain Details
Investigational Site Number : 1580003 Taichung City 404 Taiwan Details
Investigational Site Number : 1580002 Tainan 704 Taiwan Details
Investigational Site Number : 1580005 Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field